Lipid Management in Human Immunodeficiency Virus

被引：9

作者：

Myerson, Merle ^{[1
]}

机构：

[1] Mt Sinai Roosevelt, Mt Sinai St Lukes, Inst Adv Med HIV, Cardiovasc Dis Prevent Program, 1111 Amsterdam Ave, New York, NY 10025 USA

来源：

ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA | 2016年 / 45卷 / 01期

关键词：

HIV; Dyslipidemia; Cardiovascular risk factors; Antiretroviral therapy; Infectious diseases; HIV-INFECTED PATIENTS; ACTIVE ANTIRETROVIRAL THERAPY; LOW-DENSITY-LIPOPROTEIN; CARDIOLOGY/AMERICAN HEART ASSOCIATION; POLYUNSATURATED FATTY-ACIDS; EXTENDED-RELEASE NIACIN; 2013; AMERICAN-COLLEGE; CARDIOVASCULAR-DISEASE; LDL-CHOLESTEROL; FISH-OIL;

D O I：

10.1016/j.ecl.2015.09.010

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The development of antiretroviral medications to treat patients infected with HIV has changed this disease from one that was fatal to a chronic and more manageable condition. However, these patients are at increased risk for cardiovascular disease due to the HIV itself, use of antiretroviral medications, and because they are living to an age when cardiovascular disease is more prevalent. At present there are no specific guidelines for management of risk factors, in particular dyslipidemia, for this patient population. We present recommendations based on those for the general population and how these may be applied to patients living with HIV.

引用

页码：141 / +

页数：30

共 115 条

[1] A randomized trial of the efficacy and safety of fenofibrate versus pravastatin in HIV-infected subjects with lipid abnormalities: AIDS Clinical Trials Group Study 5087 [J].

Aberg, JA ;

Zackin, RA ;

Brobst, SW ;

Evans, SR ;

Alston, BL ;

Henry, WK ;

Glesby, MJ ;

Torriani, FJ ;

Yang, YJ ;

Owens, SI ;

Fichtenbaum, CJ .

AIDS RESEARCH AND HUMAN RETROVIRUSES, 2005, 21 (09) :757-767

[2]

Aberg JA, 2013, NEUTRAL EFFECTS PITA

[3]

Aberg JA, 2014, CLIN INFECT DIS, V58, pE1, DOI [10.1093/cid/cit665, 10.1093/cid/cit757]

[4] Mapping the Journey to an HIV Vaccine [J].

Ackerman, Margaret ;

Alter, Galit .

NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (04) :389-391

[5] Independent Predictors of Metabolic Syndrome in HIV-Infected Patients [J].

Alencastro, Paulo R. ;

Fuchs, Sandra C. ;

Wolff, Fernando H. ;

Ikeda, Maria Leticia ;

Brandao, Ajacio B. M. ;

Barcellos, Nemora T. .

AIDS PATIENT CARE AND STDS, 2011, 25 (11) :627-634

[6] Association of serum lipid levels with HIV serostatus, specific antiretroviral agents, and treatment regimens [J].

Anastos, Kathryn ;

Lu, Dalian ;

Shi, Qiuhu ;

Tien, Phyllis C. ;

Kaplan, Robert C. ;

Hessol, Nancy A. ;

Cole, Steven ;

Vigen, Cheryl ;

Cohen, Mardge ;

Young, Mary ;

Justman, Jessica .

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2007, 45 (01) :34-42

[7] 2012 Update of the Canadian Cardiovascular Society Guidelines for the Diagnosis and Treatment of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult [J].

Anderson, Todd J. ;

Gregoire, Jean ;

Hegele, Robert A. ;

Couture, Patrick ;

Mancini, G. B. John ;

McPherson, Ruth ;

Francis, Gordon A. ;

Poirier, Paul ;

Lau, David C. ;

Grover, Steven ;

Genest, Jacques, Jr. ;

Carpentier, Andre C. ;

Dufour, Robert ;

Gupta, Milan ;

Ward, Richard ;

Leiter, Lawrence A. ;

Lonn, Eva ;

Ng, Dominic S. ;

Pearson, Glen J. ;

Yates, Gillian M. ;

Stone, James A. ;

Ur, Ehud .

CANADIAN JOURNAL OF CARDIOLOGY, 2013, 29 (02) :151-167

[8]

[Anonymous], MED LETT DRUGS THER

[9]

[Anonymous], 1981, PNEUMOCYSTITIS PNEUM, V30, P1

[10]

[Anonymous], 2008, CIRCULATION

← 1 2 3 4 5 6 7 8 9 10 →